Brief: Vaxcyte Q2 Operating Expenses USD 152.981 Million
Aug 06 (Reuters) - Vaxcyte Q2 net income USD -128.703 million vs. IBES estimate USD -111.5 million
Aug 06 (Reuters) - Vaxcyte Q2 net income USD -128.703 million vs. IBES estimate USD -111.5 million